The Mexico pulmonary arterial hypertension drugs market is growing due to increasing disease awareness, better diagnostic capabilities, and access to advanced therapies. Demand for targeted treatments, including endothelin receptor antagonists and prostacyclin analogs, continues to rise. Supportive healthcare policies and expanded patient care programs also contribute to market expans... https://www.imarcgroup.com/mexico-pulmonary-arterial-hypertension-drugs-market